Cargando…
Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients
BACKGROUND: Progression to stage IV disease remains the main cause of breast cancer-related deaths. Increasing knowledge on the hematogenous phase of metastasis is key for exploiting the entire window of opportunity to interfere with early dissemination and to achieve a more effective disease contro...
Autores principales: | Fina, Emanuela, Cleris, Loredana, Dugo, Matteo, Lecchi, Mara, Ciniselli, Chiara Maura, Lecis, Daniele, Bianchi, Giulia Valeria, Verderio, Paolo, Daidone, Maria Grazia, Cappelletti, Vera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876758/ https://www.ncbi.nlm.nih.gov/pubmed/35216615 http://dx.doi.org/10.1186/s13046-022-02259-8 |
Ejemplares similares
-
The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models
por: Cleris, Loredana, et al.
Publicado: (2019) -
Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods
por: Fina, Emanuela, et al.
Publicado: (2017) -
COVID-19 Vaccination in Health Care Workers in Italy: A Literature Review and a Report from a Comprehensive Cancer Center
por: Ciniselli, Chiara Maura, et al.
Publicado: (2022) -
Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma(1)
por: Fina, Emanuela, et al.
Publicado: (2016) -
Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)